WELLTANA INC. / WEBSITE INFORMATION
HIPAA Notice
Draft — pending confirmation and legal review. This page is being prepared and is not a final adopted policy. Effective date: [CONTENT NEEDED].
Notice of Privacy Practices
[CONTENT NEEDED] Welltana’s approved Notice of Privacy Practices, effective date, privacy officer, mailing address, and the practices of any organizations covered by the notice. This draft is not an adopted HIPAA notice or an authorization to share health information.
Your health information rights
A completed notice must explain applicable rights to access and request corrections to health records, request confidential communications or restrictions, obtain information about certain disclosures, receive a copy of the notice, and raise privacy complaints.
How health information is used and shared
[CONTENT NEEDED] Explain Welltana’s actual permitted uses and disclosures, authorization requirements and revocation process, privacy duties, breach notification obligations, and applicable limitations. Do not infer these practices from the general website contact form.
Substance-use treatment records
[CONTENT NEEDED] Confirm whether Welltana is a federally assisted program subject to 42 CFR Part 2 and prepare the applicable patient notice or combined HIPAA/Part 2 notice. Include required consent, redisclosure, and legal-proceeding protections using the current HHS model and Welltana’s confirmed practices.
Questions, copies, and complaints
Call 747.368.9396 or email contact@welltana.com to ask for Welltana’s approved privacy notice or privacy contact. [CONTENT NEEDED] Confirm the privacy officer’s direct contact, internal complaint procedure, and all required complaint and non-retaliation statements.
Official guidance
The U.S. Department of Health and Human Services provides model notices covering HIPAA and substance-use treatment records. The final Welltana notice must be completed for its actual operations and reviewed before adoption.